RheumNow Live 2024

1. Overview
The RheumNow Live 2024 course provides a comprehensive clinical update on the diagnosis and management of complex rheumatic and autoimmune diseases. The program features expert-led sessions on the latest therapeutic advancements, clinical guidelines, and emerging biomarkers across core rheumatology domains, including SLE, rheumatoid arthritis, psoriatic disease, and spondyloarthritis.
Course Date: 2024
2. Learning Objectives

Evaluate the biology of lupus flares and implement emerging biomarkers for the accurate diagnosis and treatment of SLE.

Apply updated ACR, EULAR, and GRAPPA guidelines for the selection of systemic therapies in psoriatic disease and spondyloarthritis.

Assess the clinical efficacy, safety concerns, and expanding applications of JAK inhibitors within the rheumatology treatment paradigm.

Formulate proactive clinical strategies for the prevention and nutritional management of rheumatoid arthritis.

Implement evidence-based approaches for managing ANCA-associated vasculitis, addressing pregnancy complexities, and mitigating malignancy risks in myositis.

3. Target Audience

Best for rheumatologists and clinical immunologists who want updates on SLE, rheumatoid arthritis, JAK inhibitors, and spondyloarthritis.

4. Topics

Adjourn

Biology and Rx of Lupus Flares

BONUS STEP

Choosing Systemic Therapies for Psoriatic Disease

CurrentFuture Biomarkers in SLE

Enthesitis in Spondyloarthritis

EULAR vs ACR vs GRAPPA Guidelines

Expanding Use of JAK Inhibitors in Dermatology

Future Therapy of Axial Spondyloarthritis

Gender Differences in PsA Outcomes Management

GPA Managment in 2024

JAK Faculty QA

JAK Inhibition in Spondyloarthritis

JAK Inhibitors in the Paradigm

Lessons from Cardio-Rheumatology Clinic

Mastering SLE

Nonradiographic Axial Spondyloarthritis

Nutrition in RA

Prevention of RA

Psoriatic Arthritis – Hot Topics

Psoriatic Faculty QA

RA Faculty Panel QA

Rethinking Pre-Clinical Disease in Lupus

Rheumatoid Arthritis Success in Rheumatoid Arthritis

Safety Concerns with JAK Inhibitors

SLE Faculty Panel QA

Spondyloarthritis Faculty Panel QA

Spondyloarthritis Spectrum

STEP Appreciative Rheumatology Building On The Positive

STEP Dead Words Eulogy

STEP Ethics in Rheumatology

STEP Immunosenescence in RA

STEP Lest we forget the flare

STEP Myositis Malignancy Risk Screening

STEP Myths Mistakes on ANCA-Associated Vasculitis

Treat to Target in Vasculitis

Vasculitis Faculty Panel QA

Vasculitis Mavens

Vasculitis Pregnancy

VIRTUAL SHOWCASE – Clinical Relevance of High Rheumatoid Factor in Patients With Rheumatoid Arthritis Non-CME

VIRTUAL SHOWCASE – DEFY Expectations Challenge Treatment Goals in Your Adult TNFi-IR Patients with Active Psoriatic A…

Welcome Introductions